Maternal diet and infant leukemia: The DNA topoisomerase II inhibitor hypothesis: A report from the Children's Oncology Group

Cancer Epidemiology Biomarkers and Prevention

Volumn 14, Issue 3, 2005, Pages 651-655

  Spector, Logan G ^a,b   Xie, Yang ^a,b   Robison, Leslie L ^a,b   Heerema, Nyla A ^c   Hilden, Joanne M ^d   Lange, Beverly ^e   Felix, Carolyn A ^e   Davies, Stella M ^f   Slavin, Joanne ^g   Potter, John D ^h   Blair, Cindy K ^a,b   Reaman, Gregory H ⁱ   Ross, Julie A ^a,b  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c OHIO STATE UNIVERSITY   (United States)

^d LERNER RESEARCH INSTITUTE   (United States)

^e CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^f CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^g UNIVERSITY OF MINNESOTA   (United States)

^h Fred Hutchinson Cancer Research Center   (United States)

ⁱ CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GYRASE INHIBITOR;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ARTICLE; CANCER INCIDENCE; CANCER RISK; CASE CONTROL STUDY; CHILDHOOD LEUKEMIA; CONTROLLED STUDY; DIETARY INTAKE; FEMALE; FOOD; FRUIT; GENE TRANSLOCATION; HUMAN; HYPOTHESIS; INFANT; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MATERNAL NUTRITION; PREGNANCY; PRIORITY JOURNAL; QUESTIONNAIRE; VEGETABLE;

ACUTE DISEASE; ADULT; AGE OF ONSET; CASE-CONTROL STUDIES; CHILD, PRESCHOOL; DIET; DNA TOPOISOMERASES, TYPE II; ENZYME INHIBITORS; FEMALE; FRUIT; HUMANS; INFANT; INFANT, NEWBORN; LEUKEMIA, MYELOID; MALE; MATERNAL-FETAL EXCHANGE; ODDS RATIO; PREGNANCY; VEGETABLES;

EID: 20144389914     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-04-0602     Document Type: Article

References (38)

1. Ries LA, Eisner MP, Kosary CL, et al. SEER Cancer Statistics Review, 1973-2000. Bethesda (MD): National Cancer Institute; 2003.
2. Fui CH, Crist WM, Look AT. Biology and clinical significance of cytogenetic abnormalities in childhood acute lymphoblastic leukemia. Blood 1990;76:1449-63.
3. Cimino G, Lo Coco F, Biondi A, et al. ALL-1 gene at chromosome 11q23 is consistently altered in acute leukemia of early infancy. Blood 1993;82:544-6.
4. Ernst P, Wang J, Korsmeyer SJ. The role of MLL in hematopoiesis and leukemia. Curr Opin Hematol 2002;9:282-7.
5. Gale KB, Ford AM, Repp R, et al. Backtracking leukemia to birth: identification of clonotypic gene fusion sequences in neonatal blood spots. Proc Natl Acad Sci U S A 1997;94:13950-4.
6. Greaves MF, Maia AT, Wiemels JL, Ford AM. Leukemia in twins: lessons in natural history. Blood 2003;102:2321-33.
7. Gewirtz DA. Does bulk damage to DNA explain the cytostatic and cytotoxic effects of topoisomerase II inhibitors? Biochem Pharmacol 1991;42:2253-8.
8. Zandvliet DW, Hanby AM, Austin CA, et al. Analysis of foetal expression sites of human type II DNA topoisomerase α and β mRNAs by in situ hybridisation. Biochim Biophys Acta 1996;1307:239-47.
9. Long BH. Mechanisms of action of teniposide (VM-26) and comparison with etoposide (VP-16). Semin Oncol 1992;19:3-19.
10. Kumar L. Epipodophyllotoxins and secondary leukaemia. Lancet 1993;342:819-20.
11. Pui CH, Ribeiro RC, Hancock ML, et al. Acute myeloid leukemia in children treated with epipodophyllotoxins for acute lymphoblastic leukemia. N Engl J Med 1991;325:1682-7.
12. Andersen MK, Christiansen DH, Jensen BA, Ernst P, Hauge G, Pedersen-Bjergaard J. Therapy-related acute lymphoblastic leukaemia with MLL rearrangements following DNA topoisomerase II inhibitors, an increasing problem: report on two new cases and review of the literature since 1992. Br J Haematol 2001;114:539-43.
13. Ross JA, Potter JD, Robison LL. Infant leukemia, topoisomerase II inhibitors, and the MLL gene. J Natl Cancer Inst 1994;86:1678-80.
14. Ross JA, Kasum CM. Dietary flavonoids: bioavailability, metabolic effects, and safety. Annu Rev Nutr 2002;22:19-34.
15. Austin CA, Patel S, Ono K, Nakane H, Fisher LM. Site-specific DNA cleavage by mammalian DNA topoisomerase II induced by novel flavone and catechin derivatives. Biochem J 1992;282:883-9.
16. Yamashita Y, Kawada S, Nakano H. Induction of mammalian topoisomerase II dependent DNA cleavage by nonintercalative flavonoids, genistein and orobol. Biochem Pharmacol 1990;39:737-44.
17. Strick R, Strissel PL, Borgers S, Smith SL, Rowley JD. Dietary bioflavonoids induce cleavage in the MLL gene and may contribute to infant leukemia. Proc Natl Acad Sci U S A 2000;97:4790-5.
18. Ross JA, Potter JD, Reaman GH, Pendergrass TW, Robison LL. Maternal exposure to potential inhibitors of DNA topoisomerase II and infant leukemia (United States): a report from the Children's Cancer Group. Cancer Causes Control 1996;7:581-90.
19. Wiemels JL, Pagnamenta A, Taylor GM, Eden OB, Alexander FE, Greaves MF. A lack of a functional NAD(P)H:quinone oxidoreductase allele is selectively associated with pediatric leukemias that have MLL fusions. United Kingdom Childhood Cancer Study Investigators. Cancer Res 1999;59:4095-9.
20. Smith MT, Wang Y, Skibola CF, et al. Low NAD(P)H:quinone oxido reductase activity is associated with increased risk of leukemia with MLL translocations in infants and children. Blood 2002;100:4590-3.
21. Potter JD, editor. Food, nutrition and the prevention of cancer: a global perspective. Washington (DC): World Cancer Research Fund and American Institute for Cancer Research; 1997.
22. Ross JA, Severson RK, Pollock BH, Robison LL. Childhood cancer in the United States. A geographical analysis of cases from the Pediatric Cooperative Clinical Trials groups. Cancer 1996;77:201-7.
23. Robison LL, Daigle A. Control selection using random digit dialing for cases of childhood cancer. Am J Epidemiol 1984;120:164-6.
24. Bennett JM, Catovsky D, Daniel MT, et al. Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group. Ann Intern Med 1985;103:620-5.
25. Bennett JM, Catovsky D, Daniel MT, et al. The morphological classification of acute lymphoblastic leukaemia: concordance among observers and clinical correlations. Br J Haematol 1981;47:553-61.
26. Behm FG, Raimondi SC, Frestedt JL, et al. Rearrangement of the MLL gene confers a poor prognosis in childhood acute lymphoblastic leukemia, regardless of presenting age. Blood 1996;87:2870-7.
27. Flanders WD, Kleinbaum DG. Basic models for disease occurrence in epidemiology. Int J Epidemiol 1995;24:1-7.
28. Maldonado G, Greenland S. Simulation study of confounder-selection strategies. Am J Epidemiol 1993;138:923-36.
29. Slattery ML, Edwards SL, Caan BJ, Kerber RA, Potter JD. Response rates among control subjects in case-control studies. Ann Epidemiol 1995;5:245-9.
30. Felix CA, Lange BJ, Hosler MR, Fertala J, Bjornsti MA. Chromosome band 11q23 translocation breakpoints are DNA topoisomerase II cleavage sites. Cancer Res 1995;55:4287-92.
31. Bunin GR, Gyllstrom ME, Brown JE, Kahn EB, Kushi LH. Recall of diet during a past pregnancy. Am J Epidemiol 2001;154:1136-42.
32. Fortune JM, Osheroff N. Topoisomerase II as a target for anticancer drugs: when enzymes stop being nice. Prog Nucleic Acid Res Mol Biol 2000;64:221-53.
33. Willett WC, Howe GR, Kushi LH. Adjustment for total energy intake in epidemiologic studies. Am J Clin Nutr 1997;65:1220-8S; discussion 1229-31S.
34. McDonald TA, Holland NT, Skibola C, Duramad P, Smith MT. Hypothesis: phenol and hydroquinone derived mainly from diet and gastrointestinal flora activity are causal factors in leukemia. Leukemia 2001;15:10-20.
35. Riboli E, Norat T. Epidemiologic evidence of the protective effect of fruit and vegetables on cancer risk. Am J Clin Nutr 2003;78:559-69S.
36. Gurney JG, Smith MA, Olshan AF, Hecht SS, Kasum CM. Clues to the etiology of childhood brain cancer: N-nitroso compounds, polyomaviruses, and other factors of interest. Cancer Invest 2001;19:630-40.
37. Thompson B, Demark-Wahnefried W, Taylor G, et al. Baseline fruit and vegetable intake among adults in seven 5 a day study centers located in diverse geographic areas. J Am Diet Assoc 1999;99:1241-8.
38. Li R, Serdula M, Bland S, Mokdad A, Bowman B, Nelson D. Trends in fruit and vegetable consumption among adults in 16 US states: Behavioral Risk Factor Surveillance System, 1990-1996. Am J Public Health 2000;90:777-81.